{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T05:15:37Z","timestamp":1717218937448},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2011,10,13]],"date-time":"2011-10-13T00:00:00Z","timestamp":1318464000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0026330","type":"journal-article","created":{"date-parts":[[2011,10,13]],"date-time":"2011-10-13T20:59:49Z","timestamp":1318539589000},"page":"e26330","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Therapy and Long-Term Prophylaxis of Vaccinia Virus Respiratory Infections in Mice with an Adenovirus-Vectored Interferon Alpha (mDEF201)"],"prefix":"10.1371","volume":"6","author":[{"given":"Donald F.","family":"Smee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Hui","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Ennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey D.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,10,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0166-3542(03)00008-1","article-title":"Pathogenesis and potential antiviral therapy of complications of smallpox vaccination.","volume":"58","author":"M Bray","year":"2003","journal-title":"Antiviral Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0166-3542(02)00199-7","article-title":"A review of compounds exhibiting anti-orthopoxvirus activity in animal models.","volume":"57","author":"DF Smee","year":"2003","journal-title":"Antiviral Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/095632020801900302","article-title":"Progress in the discovery of compounds inhibiting orthopoxviruses in animal models.","volume":"19","author":"DF Smee","year":"2008","journal-title":"Antivir Chem Chemother"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2174\/156652405774962326","article-title":"Countermeasures to the bioterrorist threat of smallpox.","volume":"5","author":"PB Jahrling","year":"2005","journal-title":"Curr Mol Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.3390\/v2122740","article-title":"Development of CMX001 for the Treatment of Poxvirus Infections.","volume":"2","author":"R Lanier","year":"2010","journal-title":"Viruses"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/AAC.01596-08","article-title":"ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification.","volume":"53","author":"R Jordan","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/587668","article-title":"Severe eczema vaccinatum in a household contact of a smallpox vaccinee.","volume":"46","author":"S Vora","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref8","first-page":"532","article-title":"Progressive vaccinia in a military smallpox vaccinee - United States, 2009.","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0928-8244(03)00358-4","article-title":"Prevention of lethal respiratory vaccinia infections in mice with interferon-alpha and interferon-gamma.","volume":"40","author":"G Liu","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1128\/IAI.12.1.148-155.1975","article-title":"Effect of human leukocyte interferon on vaccinia and herpes virus-infected cell cultures and monkey corneas.","volume":"12","author":"D Newmann-Haefelin","year":"1975","journal-title":"Infect Immun"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1099\/0022-1317-48-1-25","article-title":"Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon.","volume":"48","author":"W Weimar","year":"1980","journal-title":"J Gen Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1089\/jir.2009.0073","article-title":"The interferon system and vaccinia virus evasion mechanisms.","volume":"29","author":"B Perdiguero","year":"2009","journal-title":"J Interferon Cytokine Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/j.1552-4604.1987.tb03044.x","article-title":"Pharmacokinetics of interferon alpha-2b in healthy volunteers.","volume":"27","author":"E Radwanski","year":"1987","journal-title":"J Clin Pharmacol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/bdd.630","article-title":"Pharmacokinetic properties of a 40 kDa branched polyethylene glycol-modified form of consensus interferon-alpha (PEG-CIFN) in rhesus monkeys.","volume":"29","author":"Y Du","year":"2008","journal-title":"Biopharm Drug Dispos"},{"key":"ref15","first-page":"1354","article-title":"Phase I trial of consensus interferon in patients with metastatic renal cell carcinoma: toxicity and immunological effects.","volume":"9","author":"TE Hutson","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.virol.2007.07.024","article-title":"Pre- and post-exposure protection against Western equine encephalitis virus after single inoculation with adenovirus vector expressing interferon alpha.","volume":"369","author":"JQ Wu","year":"2007","journal-title":"Virology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1099\/vir.0.006833-0","article-title":"Alpha interferon as an adenovirus-vectored vaccine adjuvant and antiviral in Venezuelan equine encephalitis virus infection.","volume":"90","author":"L O'Brien","year":"2009","journal-title":"J Gen Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2010.11.007","article-title":"Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB\/c mouse model.","volume":"89","author":"Y Kumaki","year":"2011","journal-title":"Antiviral Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1128\/AAC.01635-10","article-title":"Treatment of yellow fever virus with an adenovirus-vectored interferon, DEF201, in a hamster model.","volume":"55","author":"JG Julander","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0166-3542(01)00159-0","article-title":"Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice.","volume":"52","author":"DF Smee","year":"2001","journal-title":"Antiviral Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e3548","DOI":"10.1371\/journal.pone.0003548","article-title":"Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice.","volume":"3","author":"MA Croyle","year":"2008","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0026330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T23:57:12Z","timestamp":1593129432000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0026330"}},"subtitle":[],"editor":[{"given":"Bernhard","family":"Ryffel","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,10,13]]},"references-count":21,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,10,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0026330","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,13]]}}}